Molecular Health

Molecular Health will make its analysis tools available to aid in the interpretation of raw data generated by customers of Agena's MassArray system.

The Workbench Manager helps labs manage their bioinformatics workflows while the Clinical Annotation software offers clinical variant interpretation services.

Molecular Health has renamed its portfolio ahead of planned product launches and an early-access program for its drug safety software starting in January.

The company will use the funds to continue building out its commercial platform and to drive product adoption.

Makers of NGS cancer profiling diagnostics lauded the preliminary proposal, but pointed out areas where the coverage criteria may miss patients who might benefit from testing.

The company's results add to a growing body of evidence, including from Foundation Medicine, that suggests such techniques have clinical utility for patients. 

MolecularHealth announced that Fadi Braiteh has joined its advisory board. Braiteh is an oncologist with Comprehensive Cancer Centers of Nevada, specializing in gastro-intestinal, digestive system, and breast cancers.

Diagnostics firm Epic Sciences has appointed Greg Lucier as chairman of its board of directors.

NEW YORK (GenomeWeb) – A new cancer personalized treatment service that SAP is offering to employees living with the disease provides an opportunity for the company to put its newly minted SAP Genomic Analyzer solution — a sequence alignment and analysis software that runs on the SAP Hana infrast

Pages

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.